Print PDF

Scott Liebman and Lorna Tanner Shortlisted for Attorneys of the Year by LMG Life Sciences

LMG Life Sciences

Sheppard Mullin is pleased to announce that partners Scott Liebman and Lorna Tanner have been named to the LMG Life Sciences 2022 awards shortlist in the categories of Regulatory Attorney of the Year – FDA Pharmaceutical and Patent Strategy Attorney of the Year – California, respectively.  In 2021, Lorna was also shortlisted and ultimately was selected as the Patent Strategy Attorney of the Year – California.  Both Scott and Lorna have previously been recognized by LMG Life Sciences as "Life Sciences Stars."  

In addition, the firm has been named a "Firm to Watch" in the Financial and Corporate category.

Now in its 10th year, the annual awards recognize top life sciences practitioners and law firms from the United States and Canada across a range of key practice areas—regulatory, corporate, intellectual property and litigation. Nominees are selected through a rigorous research process and interviews with leading lawyers from the field.

The winner of this year’s award will be announced at a ceremony in New York City on September 8.


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.